Search clinical trials for: All ceramic

Total 256495 results

Hangzhou Highlightll Pharmaceutical Co., Ltd

Not yet recruiting

A Study of Efficacy and Safety of TLL-018 in CSU Participants

Chronic Spontaneous Urticaria
Regeneron Pharmaceuticals

Recruiting

A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works. (ACCESS-EXT)

Paroxysmal Nocturnal Hemoglobinuria

Taiwan, Korea, Republic of, Turkey, Spain, Thailand, Singapore, Japan, Canada, Malaysia, Poland, Italy
Alzinova AB
CRST Oy

Recruiting

A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease

Alzheimer Disease | Dementia Alzheimers | Dementia, Mild

Finland
Altimmune, Inc.

Completed

Extension of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With (NAFLD)

Non-Alcoholic Fatty Liver Disease

United States
Altimmune, Inc.

Completed

ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)

Non-Alcoholic Fatty Liver Disease

United States
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute; National Institutes of Health (NIH); Medivation... and other collaborators

Active, not recruiting

Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission

AML | Acute Myelogenous Leukemia

United States
Emilio Bouza

Completed

Assessment of a Proposed Microbiological Alert and Its Impact on a Sepsis Campaign

Sepsis

Spain
Orthopedisch Centrum Oost Nederland

Active, not recruiting

Acute Anterior Cruciate Ligament Rupture; RecOnsTruction Or Repair? (ROTOR)

Anterior Cruciate Ligament Injury

Netherlands
University Hospital, Montpellier

Recruiting

Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC) (CTC-AXL-PANC)

Pancreatic Ductal Adenocarcinoma | Circulating Tumor Cell | Metastatic Pancreatic Cancer

France
Dong-A University

Completed

Efficacy of AFL-assisted PDT With Short Incubation Time in Actinic Keratosis

Actinic Keratosis

Korea, Republic of
University of Toronto
Iovate Health Sciences International Inc

Recruiting

Effect of Green Coffee Extract Combined With Alpha-Lipoic Acid on Blood Glucose Homeostasis in Healthy Adults (GCE)

Nutrition, Healthy

Canada
Tata Memorial Hospital

Completed

Fluorescence and Glioma Heterogeneity (ALAglioma)

Malignant Gliomas

India
The Leeds Teaching Hospitals NHS Trust

Recruiting

Would Artificial Intelligence Reduce Delays to Nurse Response Times (WAiRD)

Nurse's Role

United Kingdom
Apellis Pharmaceuticals, Inc.

Terminated

MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS)

Motor Neuron Disease | Amyotrophic Lateral Sclerosis

United States, Netherlands, Spain, Germany, Japan, Australia, France, Poland, Ukraine, Belgium, Czechia, Ireland, Italy, United Kingdom
Akili Interactive Labs, Inc.

Completed

Software Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to Stimulant

Attention Deficit Hyperactivity Disorder

United States
SBI Pharmaceuticals Co, Ltd.

Completed

Pilot Study to Evaluate the Safety and Efficacy of 5-ALA-SFC in Type II Diabetes

Diabetes Mellitus, Type 2
Dr. Grant Pierce

Completed

Effects of Dietary Flaxseed on Symptoms of Cardiovascular Disease in Patients With Peripheral Arterial Disease (FLAXPAD)

Peripheral Arterial Disease
Columbia University

Completed

TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Populations

Influenza

United States
Albany Molecular Research, Inc.
Westat

Terminated

A Trial of ALB 109564(a) in Subjects With Advanced Solid Tumors

Cancer

United States
Peking University Third Hospital

Recruiting

Predicting Model Based on Evidence-based Pathological Diagnose Criteria for RCC Tumor Thrombus With IVC Wall Invasion

Carcinoma, Renal Cell | Tumor Thrombus | Neoplasm Invasiveness | Inferior Vena Cava Interruption

China
Alnylam Pharmaceuticals

Active, not recruiting

A Study of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1 (ILLUMINATE-B)

Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria

United States, France, United Kingdom, Israel, Germany
Alnylam Pharmaceuticals

Active, not recruiting

A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1)

Hypertension

United States, Canada, United Kingdom, Puerto Rico, Ukraine
New York Medical College

Completed

Auto/Allo Tandem Transplant for Relapsed B-NHL

Non Hodgkin Lymphoma
Anterogen Co., Ltd.

Completed

A Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical Trial

Dystrophic Epidermolysis Bullosa

Korea, Republic of
Masonic Cancer Center, University of Minnesota

Completed

QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML

Acute Myeloid Leukemia

United States
Fenerbahce University

Completed

Evaluation of Telemedicine Practices for Contraceptive Counseling During the COVID-19 Pandemic: A Randomized Controlled Trial

Telemedicine | Pregnant Women | Women's Health | COVID-19 Pandemic | Family Planning Services

Turkey
RHEACELL GmbH & Co. KG
FGK Clinical Research GmbH; Ticeba GmbH; Granzer Regulatory Consulting & Services

Terminated

Allogeneic ABCB5-positive Stem Cells for Treatment of PAOD

Peripheral Arterial Occlusive Disease

Germany, Austria, Czechia, Poland, United Kingdom
2C Tech Corp

Completed

Intravitreal Injection of SeeQ CdSe 655 Alt Nanoparticles for Patients With Degenerative Retinal Diseases

Retinitis Pigmentosa

Mexico
M.D. Anderson Cancer Center

Terminated

A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach

Leukemia, Lymphocytic, Chronic

United States
Anterogen Co., Ltd.

Completed

A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-101 Clinical Trial

Burn

Korea, Republic of
Alios Biopharma Inc.

Completed

A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model

Respiratory Syncytial Virus Infections

United Kingdom
United Therapeutics

Completed

Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities

Pulmonary Arterial Hypertension

United States
Synvista Therapeutics, Inc
Juvenile Diabetes Research Foundation

Terminated

Study of Alagebrium in Patients With Insulin-Dependent Type 1 Diabetes and Microalbuminuria

Diabetes Mellitus, Type 1 | Diabetic Nephropathy

Australia, Denmark
Regeneron Pharmaceuticals

Recruiting

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Non-Alcoholic Fatty Liver Disease (NAFLD)

Healthy Volunteers | Non-alcoholic Fatty Liver Disease (NAFLD)

United States
Astellas Pharma Global Development, Inc.

Completed

Treatment Patterns and Key Healthcare Resource Use in Acute Myeloid Leukemia (AML) With or Without FMS-like Tyrosine Kinase-3 (FLT3) Mutation Study Based on Retrospective Chart Review

Acute Myeloid Leukemia (AML)

United States
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Juvenile...

Completed

Anti-CD3 mAb Treatment of Recent Onset Type 1 Diabetes

Type 1 Diabetes Mellitus

United States
PATH

Completed

Preliminary Evaluation of a Point-Of-Care Liver Function Test (DFA)

HIV | Tuberculosis | Drug-Induced Liver Injury

Vietnam
Alnylam Pharmaceuticals

Not yet recruiting

A Study to Evaluate Zilebesiran in Japanese Patients With Mild to Moderate Hypertension

Mild to Moderate Hypertension
Naestved Hospital

Recruiting

Oncodrivers in Malignant Pleural Effusions Associated With Non-small Cell Lung Cancer: A Prospective Study.

Non-small Cell Lung Cancer | Malignant Pleural Effusion

Denmark
Alnylam Pharmaceuticals

Approved for marketing

Expanded Access Protocol to Provide Lumasiran to Patients With Primary Hyperoxaluria Type 1

Primary Hyperoxaluria

Belgium
Anterogen Co., Ltd.

Completed

A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-201 Clinical Trial

Burn

Korea, Republic of
Alnylam Pharmaceuticals

Completed

A Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients With Polyneuropathy of ATTRv Amyloidosis With a V122I or T60A Mutation

Polyneuropathy | Hereditary Transthyretin-mediated (ATTRv) Amyloidosis

United States
Alteogen, Inc.

Completed

Clinical Study of ALT-P7 to Determine Safety, Tolerability and Pharmacokinetics in Breast Cancer Patients

HER2-positive Breast Cancer

Korea, Republic of
Parc de Salut Mar

Completed

Telephone Educational Intervention by the Gastrointestinal Endoscopy Nurse. Global Impact on the Quality of Colonoscopy

Colonic Diseases | Nurse-Patient Relations | Educational Problems

Spain
British Columbia Cancer Agency
Insight Genetics

Completed

Comparison of qPCR to IHC and FISH for Detection of ALK Fusion Mutations in FFPE Tissue From NSCLC Patients (PCRTALK)

Nonsmall Cell Lung Cancer

Canada
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France; Fondation de l'Avenir; Fondation de France; ALN Implants...

Completed

PREPIC 2 : Prevention of Recurrent Pulmonary Embolism by Vena Cava Interruption (PREPIC2)

Venous Thrombosis | Pulmonary Embolism

France
University of Toronto

Unknown

ALA and Prostate Cancer

Atrial Fibrillation | Prostate Cancer | Diet Therapy
Veloce BioPharma LLC

Completed

ALC-919 For The Treatment Of Common Warts

Verruca Vulgaris

United States
University of Minnesota
Juvenile Diabetes Research Foundation

Completed

hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1 Diabetic Islet Allograft Recipients

Hypoglycemia | Type 1 Diabetes

United States
Alnylam Pharmaceuticals

Completed

An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Participants With Primary Hyperoxaluria Type 1

Primary Hyperoxaluria | PH1 | RNAi Therapeutic | siRNA | AGT

France, United Kingdom, Netherlands, Israel, Germany

Search clinical trials for: All ceramic

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations